Ipca Laboratories Ltd share price logo

Ipca Laboratories Ltd Share Price (IPCALAB)


Get free price alerts. Set up your Free investment account to get Live Prices. >
Q1 '23 Results
News and Events

Overview of Ipca Laboratories Ltd

Key events for Ipca Laboratories Ltd

  • Ipca Labs Stock Dips 9% on Plan to Buy Stake in Unichem Lab - 03 Oct, 2023

    Shares of Ipca Laboratories Ltd fell by 9% and hit a 52-week low after the company announced plans to buy a 33.4% stake in Unichem Laboratories.

  • Ipca Laboratories Ltd Stock Rallies Over 20% - 22 Sep, 2023

    Experts suggest short-term traders can ride the momentum by accumulating the stock for a target above Rs 1000 in 1-2 months. The stock rose from Rs 731 on June 20 to Rs 913 recorded on September 20, translating into an upside of 24% in 3 months.

  • Ipca Labs Acquires Additional Stake in Unichem - 21 Sep, 2023

    Ipca Laboratories has acquired an additional 19.29% stake in Unichem Laboratories through an open offer for Rs 597.5 crore, taking its shareholding to 52.67%. This move follows Ipca's previous acquisition of 33.38% of Unichem at a price of Rs 402.25 per equity share.

  • Ipca Laboratories Stock Shows Signs of Recovery - 18 Sep, 2023

    After hitting a 52-week low, Ipca Laboratories Ltd's stock has shown signs of recovery with a fresh breakout above key levels. Analysts recommend buying at Rs 925-930 for a target of Rs 1075-1080.

  • Ipca Labs Receives Positive Classification from USFDA - 24 Aug, 2023

    Pharmaceutical company, Ipca Laboratories Ltd, reports a YoY rise in revenue and receives positive classification from the USFDA.

  • Ipca Laboratories' 1QFY24 Financial Performance Lower Than Expected - 23 Aug, 2023

    Ipca Laboratories Ltd's 1QFY24 financial performance was lower than expected due to moderated growth in international generics, API and institutional antimalaria segments. Domestic formulation continued to perform well. FY24 earnings estimate cut by 4%. Neutral rating retained.

  • Ipca Labs Acquires Stake in Unichem; Net Debt Increases - 20 Aug, 2023

    Ipca Laboratories Ltd acquires a 33.38% stake in Unichem for Rs 1,034.06 crore while its net debt increases over the past year.

  • Prabhudas Lilladher Maintains 'Hold' Rating for Ipca Laboratories - 17 Aug, 2023

    Research report by Prabhudas Lilladher states that Q1 EBITDA was in line with estimates, domestic formulation business is performing well while export business outlook remains muted. FY24/FY25E EPS estimates reduced by 12%/6%. Maintain 'Hold' rating with revised TP of Rs880/share.

  • Long Positions Added in Pharma and Healthcare Stocks - 16 Aug, 2023

    Ipca Labs, Zydus Life, and Apollo Hospitals saw the addition of long positions.

  • Ipca Labs Gains Maximum Share in Indian Pharma Market - 14 Aug, 2023

    According to recent reports, Ipca Laboratories Ltd has gained the maximum share over the past six months in the Indian pharma market.

  • Ipca Laboratories Ltd: Manufacturing and Marketing Over 350 Formulations - 11 Aug, 2023

    Ipca Laboratories Limited is an India-based pharmaceutical company that manufactures and markets over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. Its products are sold in over 100 countries across the globe.

  • Ipca Laboratories to Announce Quarterly Earnings Today - 10 Aug, 2023

    Investors will be keeping an eye on the quarterly earnings announcement of Ipca Laboratories Ltd.

  • Ipca Laboratories Ltd Shares Rise 1.09% on Unichem Acquisition - 09 Aug, 2023

    Ipca Laboratories Ltd's shares are trading higher by 1.09% at Rs. 919.55 each, with a 21.71% increase in the last month after acquiring 33.38% equity in Unichem Laboratories for Rs 945 crore.

  • Ipca Labs to Announce Quarterly Earnings - 07 Aug, 2023

    Ipca Laboratories Ltd is set to announce its quarterly earnings soon, with stock-specific action expected to continue during this period.

  • Ipca Acquires Stake in Unichem, Makes Open Offer - 03 Aug, 2023

    Ipca Laboratories Ltd acquires a 33.38% stake in Unichem for Rs 945.35 crore and makes an open offer to acquire another 26% stake. The acquisition has failed to evoke confidence among investors.

  • Ipca Acquires Stake in Unichem - 02 Aug, 2023

    Pharmaceutical company Ipca Laboratories Ltd acquired a 33.38% stake in Unichem Laboratories for Rs 945 crore and gained over 5% on the Nifty Mid-Cap 100.

  • Ipca Labs Stock Gains 3% - 31 Jul, 2023

    Ipca Laboratories Ltd's stock gained 3%, and the company is currently trading in an overbought zone with an RSI of 82.61.

  • Ipca Laboratories' ROE Predicted to Rise Despite Being Lower Than Industry Average - 29 Jul, 2023

    Despite having a lower return on equity (ROE) of 8.1% compared to the industry average of 12%, Ipca Laboratories has high earnings growth backed by its high earnings retention and heavy reinvestment of profits. The company is predicted to have an ROE of 15% in the future.

  • IPCA Labs Acquires Controlling Stake in Unichem Labs - 28 Jul, 2023

    The Competition Commission of India has approved IPCA Labs' proposal to acquire a controlling stake in Unichem Laboratories, with a 59.38% stake purchase. Additionally, IPCA's stock crossed the 200-day SMA.

  • Ipca Labs Receives Approval for Acquisition of Stake in Unichem Labs - 27 Jul, 2023

    The Competition Commission of India has approved Ipca Laboratories' proposed acquisition of up to a 59.3% stake in Unichem Laboratories for Rs 1,034 crore.

Analyst Rating for Ipca Laboratories Ltd stock

based on 20 analysts


Based on 20 analysts offering long term price targets for Ipca Laboratories Ltd. An average target of ₹859.2

Source: S&P Global Market Intelligence

Ipca Laboratories Ltd share Performance

  • ₹932
    downward going graph



    Day's Volatility:0.04%

  • ₹669.8
    downward going graph



    52 Weeks Volatility:30.59%



    downward going graph
1 Month Return6.67 %
3 Month Return25.39 %
1 Year Return0.35 %
Previous Close₹935.45
Market Cap₹23,732.76Cr

Ipca Laboratories Ltd Company Information

Ipca Laboratories is a fully integrated global pharmaceutical company, manufacturing and marketing over 350 formulations and 80 APIs in over 100 countries around the world. Established in 1949, with its original name as Indian Pharmaceutical Combine Association Limited, Ipca has 17 manufacturing units in India, producing APIs and Formulations that are approved by major drug regulatory authorities, including the US FDA, UK MHRA, South African MCC, Brazilian ANVISA and Australian TGA. Apart from native India, Ipca is also a recognized supplier of intermediates and APIs⁠—Atenolol, Chloroquine Phosphate, Furosemide, and Pyrantel Salts⁠—globally. Ipca has received accreditation from ISO 9001, Forbes Global 200 best small companies, WHOGMP, INVIMA Colombian, and German standards, making it a respected name in the pharmaceutical industry. Recently, Ipca has acquired a number of companies, namely Krebs Biochemicals and Industries Ltd., Pisgah Labs Inc., Trophic Wellness Private Ltd, Lyka Labs Limited, and M/s. Ramdev Chemical Private Limited, to further extend its presence in the global market.

Share Price: ₹932.35 per share as on 04 Oct, 2023 11:12 AM
Market Capitalisation: ₹23,732.76Cr as of today
Revenue: ₹1,548.02Cr as on March 2023 (Q1 23)
Net Profit: ₹76.52Cr as on March 2023 (Q1 23)
Listing date: 03 Nov, 1994
Chairperson Name: Premchand Godha
OrganisationIpca Laboratories Ltd
E-voting on sharesClick here to vote

Fundamentals of Ipca Laboratories Ltd

Insights on Ipca Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.


    MF Holding Up

    Mutual Funds have increased holdings from 29.94% to 30.27% in Jun 2023 quarter

  • imgNO EFFECT

    Against Peers

    In the last 1 year, Dr Reddys Laboratories Ltd has given 26.4% return, outperforming this stock by 26.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    Promoters holdings remained unchanged at 46.29% of holdings in Jun 2023 quarter

  • imgNO EFFECT

    Against Peers

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 121.5% return, outperforming this stock by 134.5%


    Revenue Fall

    Revenue is down for the last 3 quarters, 1.63K Cr → 1.54K Cr (in ₹), with an average decrease of 2.8% per quarter


    Profit Down

    Netprofit is down for the last 3 quarters, 143.9 Cr → 76.52 Cr (in ₹), with an average decrease of 27.1% per quarter


    FII Holding Down

    Foreign Institutions have decreased holdings from 10.58% to 10.05% in Jun 2023 quarter


    Price Dip

    In the last 3 years, IPCALAB stock has moved down by -13.0%


    Retail Holding Down

    Retail Investor have decreased holdings from 9.07% to 8.48% in Jun 2023 quarter

Ipca Laboratories Ltd share Valuation

Ipca Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (18.72x)

October 10, 2019

Today (48.32x)

October 3, 2023

Industry (48.86x)

October 3, 2023

Highest (48.33x)

September 29, 2023


Mutual Fund Holdings

Funds Holdings
HDFC Mid-Cap Opportunities Fund -Direct Plan - Growth OptionHDFC Mid-Cap Opportunities Fund -Direct Plan - Growth Option2.45%
Kotak Emerging Equity Scheme Direct GrowthKotak Emerging Equity Scheme Direct Growth1.82%
DSP Midcap Fund Direct Plan GrowthDSP Midcap Fund Direct Plan Growth3.31%
Parag Parikh Flexi Cap Direct GrowthParag Parikh Flexi Cap Direct Growth0.76%
DSP Small Cap Fund Direct Plan GrowthDSP Small Cap Fund Direct Plan Growth2.33%

Ipca Laboratories Ltd Shareholding Pattern

InvestorsHoldings %Prev. 2 periods3M change
Promoter Holdings
Foreign Institutions
Mutual Funds
Retail Investors

Technicals of Ipca Laboratories Ltd share

News & Events of Ipca Laboratories Ltd

Frequently Asked Questions

Ipca Laboratories Ltd (IPCALAB) share price today is ₹932.35

  • Today’s highest price of Ipca Laboratories Ltd is ₹932.35.
  • Today’s lowest price of Ipca Laboratories Ltd is ₹932.

Today’s traded volume of Ipca Laboratories Ltd(IPCALAB) is 4.38L.

Today’s market capitalisation of Ipca Laboratories Ltd(IPCALAB) is ₹23732.76Cr.

Ipca Laboratories Ltd(IPCALABPrice
52 Week High
52 Week Low

Ipca Laboratories Ltd(IPCALAB) share price is ₹932.35. It is down -2.37% from its 52 Week High price of ₹955

Ipca Laboratories Ltd(IPCALAB) share price is ₹932.35. It is up 39.20% from its 52 Week Low price of ₹669.8

Ipca Laboratories Ltd(IPCALABReturns
1 Day Returns
1 Month Returns
3 Month Returns
1 Year Returns